Thursday, May 21, 2026 6:36:57 AM
I’m not insisting on proof of the final outcome. I’m pointing out the lack of proof for the jackpot award being promoted now. Those are different things.
Saying there is “no proof of anything until the process is completed” goes too far. There may be no final judgment or final settlement number yet, but that does not mean the case cannot be evaluated. This is not some new legal frontier where everyone is guessing in the dark. We have the complaint, the court’s rulings, the surviving claims, the narrowed scope, the statutory framework, and precedent that applies to securities cases. Those facts do not prove the final settlement value, but they do provide a basis to judge a possible outcome.
You also say, “This case has been as much about the pain and risk the defendants are exposed to during discovery.” What proof do you have of that? Discovery can create cost and risk, yes. It can be expensive, distracting, and sometimes it reveals facts that change the value of a case. But saying this case has been “as much about” discovery as actual damages is just your opinion.
If the argument is that discovery may create leverage and may lead to additional settlements, fine. That is possible. But that is a long way from saying this case supports some huge award.
Same with the idea that discovery may reveal other causes of action. It may reveal additional facts, but new claims are not automatic. NWBO would still have to amend, survive motion practice, prove causation, and connect any new claim to legally recoverable damages.
So my point remains the same. Possibility is not proof. Discovery pressure is not the same as actual damages. And based on the current record, I barely see a path to even a few million, let alone the billions being promoted here.
Saying there is “no proof of anything until the process is completed” goes too far. There may be no final judgment or final settlement number yet, but that does not mean the case cannot be evaluated. This is not some new legal frontier where everyone is guessing in the dark. We have the complaint, the court’s rulings, the surviving claims, the narrowed scope, the statutory framework, and precedent that applies to securities cases. Those facts do not prove the final settlement value, but they do provide a basis to judge a possible outcome.
You also say, “This case has been as much about the pain and risk the defendants are exposed to during discovery.” What proof do you have of that? Discovery can create cost and risk, yes. It can be expensive, distracting, and sometimes it reveals facts that change the value of a case. But saying this case has been “as much about” discovery as actual damages is just your opinion.
If the argument is that discovery may create leverage and may lead to additional settlements, fine. That is possible. But that is a long way from saying this case supports some huge award.
Same with the idea that discovery may reveal other causes of action. It may reveal additional facts, but new claims are not automatic. NWBO would still have to amend, survive motion practice, prove causation, and connect any new claim to legally recoverable damages.
So my point remains the same. Possibility is not proof. Discovery pressure is not the same as actual damages. And based on the current record, I barely see a path to even a few million, let alone the billions being promoted here.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
